Filing Details
- Accession Number:
- 0001602264-19-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-20 16:08:57
- Reporting Period:
- 2019-03-18
- Accepted Time:
- 2019-03-20 16:08:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1348911 | Kalvista Pharmaceuticals Inc. | KALV | Pharmaceutical Preparations (2834) | 200915291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1602263 | Vhcp Management Ii, Llc | C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304 | No | No | Yes | No | |
| 1602264 | Venrock Healthcare Capital Partners Ii, L.p. | C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304 | No | No | Yes | No | |
| 1615979 | Y Bong Koh | C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304 | No | No | Yes | No | |
| 1615983 | Vhcp Co-Investment Holdings Ii, Llc | C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304 | No | No | Yes | No | |
| 1698082 | P Nimish Shah | C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304 | No | No | Yes | No | |
| 1738048 | Venrock Healthcare Capital Partners Iii, L.p. | C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304 | No | No | Yes | No | |
| 1738053 | Vhcp Management Iii, Llc | C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304 | No | No | Yes | No | |
| 1750761 | Vhcp Co-Investment Holdings Iii, Llc | C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-03-18 | 500,000 | $28.75 | 1,544,112 | No | 4 | S | Indirect | By Funds |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Funds |
Footnotes
- Consists of (i) 408,110 shares held by Venrock Healthcare Capital Partners II, L.P. ("VHCP2"), (ii) 165,372 shares held by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 882,461 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3") and (iv) 88,169 shares held by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3").
- VHCP Management II, LLC ("VHCPM2") is the general partner of VHCP2 and the manager of VHCP Co-2 and may be deemed to beneficially own these shares. VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these shares. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3 and may be deemed to beneficially own these shares. Each of VHCPM2, VHCPM3, Bong Koh and Nimish Shah expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein.
Billionaire Hedge Funds
